Loading
Latest filing published 24 Oct 2025 for Xvivo Perfusion Aktiebolag, €18k.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Erik Strömqvist is a declared insider of Xvivo Perfusion Aktiebolag, with filings sourced from Finansinspektionen. In total, 2 filings cover trades dated from 14 November 2024 to 24 October 2025.
Every open-market trade on record is a purchase: 2 purchases worth €48k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2025: 1 purchase and no sales on the market.
The record was last updated on 24 October 2025 with an open-market purchase (€18k) in Xvivo Perfusion Aktiebolag. These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations